Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?

MH Kazemi, M Sadri, A Najafi, A Rahimi… - Frontiers in …, 2022 - frontiersin.org
Tumor-infiltrating lymphocytes (TILs), frontline soldiers of the adaptive immune system, are
recruited into the tumor site to fight against tumors. However, their small number and …

Dendritic cells as orchestrators of anticancer immunity and immunotherapy

I Heras-Murillo, I Adán-Barrientos, M Galán… - Nature Reviews …, 2024 - nature.com
Dendritic cells (DCs) are a heterogeneous group of antigen-presenting innate immune cells
that regulate adaptive immunity, including against cancer. Therefore, understanding the …

A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion

SM **, YJ Yoo, HS Shin, S Kim, SN Lee… - Nature …, 2023 - nature.com
Although conventional innate immune stimuli contribute to immune activation, they induce
exhausted immune cells, resulting in suboptimal cancer immunotherapy. Here we suggest a …

Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer

Q Mu, G Lin, M Jeon, H Wang, FC Chang, RA Revia… - Materials Today, 2021 - Elsevier
Triple negative breast cancer (TNBC) is difficult to treat effectively, due to its aggressiveness,
drug resistance, and lack of the receptors required for hormonal therapy, particularly at the …

Type I and II interferons in the anti-tumor immune response

SE Fenton, D Saleiro, LC Platanias - Cancers, 2021 - mdpi.com
Simple Summary Interferons are cytokines that play key roles in the activation of cellular
components of the immune response, such as dendritic cells, macrophages and T cells …

Dendritic cells and cancer immunotherapy: The adjuvant effect

S Nava, D Lisini, S Frigerio, A Bersano - International Journal of …, 2021 - mdpi.com
Dendritic cells (DCs) are immune specialized cells playing a critical role in promoting
immune response against antigens, and may represent important targets for therapeutic …

Immunotherapeutic implications of toll-like receptors activation in tumor microenvironment

R Zheng, J Ma - Pharmaceutics, 2022 - mdpi.com
Toll-like receptors (TLRs) play an important role between innate and adaptive immunity as
one of the pattern recognition receptors (PRRs). Both immune cells and tumor cells express …

Clinical and molecular insights into BCG immunotherapy for melanoma

M Kremenovic, M Schenk… - Journal of internal …, 2020 - Wiley Online Library
The incidence of cutaneous melanoma and the mortality rate of advanced melanoma
patients continue to rise globally. Despite the recent success of immunotherapy including …

[HTML][HTML] A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses

CC Bozkus, AB Blazquez, T Enokida, N Bhardwaj - STAR protocols, 2021 - Elsevier
Determining the antigen specificities of the endogenous T-cell repertoire is important for
screening naturally occurring or therapy-induced T-cell immunity and may help identify …

[HTML][HTML] Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells

M He, B Soni, PC Schwalie, T Hüsser… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Dendritic cells (DCs) are professional antigen presenting cells that initiate
immune defense to pathogens and tumor cells. Human tumors contain only few DCs that …